Markers of bone resorption in patients treated with pamidronate

This publication has 22 references indexed in Scilit:

• Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study
  Cancer, 1994
• A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine
  Journal of Bone and Mineral Research, 1992
• Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases
  European Journal of Clinical Investigation, 1991
• Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma.
  BMJ, 1988
• Single dose versus daily intravenous aminohydroxypropylidene biphosphonate (APD) for the hypercalcaemia of malignancy
  BMJ, 1988
• REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT
  The Lancet, 1987
• Pyridinium crosslinks of bone collagen and their location in peptides isolated from rat femur
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1987
• A novel fluor in insoluble collagen: A crosslinking moiety in collagen molecule
  Biochemical and Biophysical Research Communications, 1982
• The structure of pyridinoline, a collagen crosslink
  Biochemical and Biophysical Research Communications, 1978
• Mechanisms of bone destruction in the development of skeletal metastases
  Nature, 1976